Where does Odyssey Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Odyssey Therapeutics's 4 recorded funding rounds.

Premier Alternatives

Odyssey Therapeutics

Biotechnology · Boston, MA · Founded 2018 · In IPO Registration

Operator of a biotechnology company intended to develop immunomodulators and oncology drugs. Odyssey Therapeutics is based in Boston, MA and was founded in 2018. It is valued at about $638 million as of Oct 2026, set by institutional fund marks. It has raised $716 million across 4 recorded rounds; the latest was a $214 million later-stage round in Jun 2025.

PMV mark · valuation

$638.2M

Oct 2026

Priced at

—

Total raised

$716.2M

Last round

Later Stage VC

Jun 2025

Cap table — not yet on record

Odyssey Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on Odyssey Therapeutics

·1 fund mark: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about Odyssey Therapeutics

Where does Odyssey Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Odyssey Therapeutics's 4 recorded funding rounds.